Under PDUFA V, FDA committed to hold a series of meetings to obtain patient input on 20 diseases as part of the agency's Patient-Focused Drug Development initiative. Last September, FDA solicited public comments on a preliminary list of 39 disease candidates. This month, agency announced the first 16, which will be discussed during fiscal 2013-15. It includes four diseases